Creo Medical Group PLC - Chepstow, Wales-based medical device company focused on surgical endoscopy - Will collaborate with Khalifa University of Science & Technology in Abu Dhabi. Says partnership has an initial focus on healthcare challenges relevant to the population in the United Arab Emirates, as well as the wider Middle East and North Africa region. Chief Executive Officer Craig Gulliford says: "As part of our strategy, we are driven to exploit our IP either directly or in partnership with third-parties, as shown by our robotic assisted surgery collaborations. Khalifa University is a research-intensive organisation with a similar drive to develop and commercially exploit leading technologies, at scale and on a global basis. The combination of Creo's people, technology and IP with Khalifa University's teams, technologies, facilities and resources represents a great opportunity for both organisations to advance and commercialise incremental technology and products and enhance research profiles internationally."
Current stock price: 41.38 pence, down 0.9%
12-month change: more than doubled from 18.94 pence
By Sabrina Penty, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Creo Medical (CREO)